Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Fact Sheets

Governance

Board Documents

Guidelines

Press Releases

Immunization Information

Immunization Forum
Latest Issue

GAVI Update

Glossary

Employment

11th GAVI BOARD MEETING
Washington, DC, 15-16 July 2003
SUMMARY REPORT

>>Back to the 11th GAVI Board Meeting

Documents
Background paper and CV
(Word - 137K)

11. Board Turnover

  • Technical Institutes: The term of the US Centers for Disease Control and Prevention (CDC) in the Technical Institutes seat ended December 2002. The only candidate for the seat, the International Vaccine Instititute, has made it clear that it will be unable to pay the Board fee.


  • OECD Countries: France, represented by Secretary of State for Foreign Affairs Renaud Muselier, has been nominated to fill this seat.


  • R&D: Six nominations were received for the GAVI R&D seat: Gothenburg University, Sweden; the International AIDS Vaccine Initiative (IAVI), USA; Istituto Superiore di Sanita, Italy; London School of Hygiene & Tropical Medicine, U.K.; National Public Health Institute (KTL), Finland; and The Oswaldo Cruz Foundation, Brazil. The candidates were assessed based on the following criteria:
    • Knowledge and experience in vaccine development (R & D)


    • Managerial experience


    • Developing country experience


    • Ability to pay Board seat fee (only applicable to OECD country candidates)


    • Geographical distribution on GAVI Board


DECISIONS

The Board:

    11.1 Endorsed the recommendation to extend the CDC's term until the end of 2003 in order to launch a new search for a replacement. The CDC will need to examine whether it will be able to pay the Board fee for 2003, and to inform the Board who will replace David Fleming as the CDC representative.

    11.2 Endorsed the recommendation from Institut Pasteur to accept the nomination of Gothenburg University, represented by Professor Jan Holmgren, to fill the R&D seat. Professor Holmgren will serve on the ADIP Management Committee; he will assume the chair of this committee in October, succeeding Rick Klausner.

    11.3 Endorsed the nomination of France, represented by Secretary of State for Foreign Affairs Renaud Muselier.

    11.4 Requested the Secretariat to work with the Chair to send official notification to the new Board members.

    11.5 Reconfirmed its support for the requirement of Board fees, as it signifies Board members' commitment to GAVI.

>>Back to the 11th GAVI Board Meeting

star_int   Contact us | Guestbook | Copyrights | Text site